0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Auto-disable Syringes Market by Indication, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5313870
UP TO EUR$697USDGBP OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Auto-disable Syringes Market grew from USD 23.28 billion in 2023 to USD 25.94 billion in 2024. It is expected to continue growing at a CAGR of 11.54%, reaching USD 50.01 billion by 2030.

Auto-disable syringes have emerged as a fundamental necessity in preventing needle reuse and ensuring patient safety, primarily due to their one-time-use feature designed to lock or disable after a single administration of medication or vaccine. The necessity for these syringes is underscored by increasing global vaccination drives, campaigns aimed at reducing healthcare-associated infections, and growing awareness regarding safe injection practices. Their primary application lies in the healthcare sector, particularly in immunization programs where high precision and safety are mandated. The end-use scope is extensive, covering hospitals, clinics, and community health centers striving to adhere to stringent safety protocols. Market insights reveal that the global push for enhanced healthcare safety standards and supportive government regulations are key factors propelling market growth. The increasing burden of infectious diseases like HIV and hepatitis has encouraged the adoption of safer injection methodologies, providing significant opportunities for market expansion. Innovations in syringe materials and mechanisms to incorporate better safety features and cost-efficiency are pivotal business growth areas. However, one of the major challenges lies in the manufacturing cost and pricing pressures, which can limit widespread adoption, especially in developing regions with constrained healthcare budgets. Distribution challenges and the lack of adequate training and awareness among healthcare workers in certain areas can also impede market expansion. To capitalize on market opportunities, companies should invest in R&D for affordable design innovations and collaborate with governments and NGOs to enhance distribution networks. Additionally, exploring partnerships for educational campaigns can address awareness deficits effectively. The nature of this market is competitive and innovatively oriented, which underscores the importance of capturing technological advancements and advocating for supportive regulatory frameworks to promote broader adoption and mitigate potential challenges in global healthcare settings.

Understanding Market Dynamics in the Auto-disable Syringes Market

The Auto-disable Syringes Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising incidence of needle stick injuries and cross infection
    • Significant preference of healthcare organizations towards the use of auto-disable syringes
    • Increasing demand for immunization coverage
  • Market Restraints
    • High cost of procurement and raw material
  • Market Opportunities
    • Increasing scope in mass application campaign
    • Ongoing advancements in auto-disable syringes
  • Market Challenges
    • Concern regarding unsafe injection practices and logistic challenges

Exploring Porter’s Five Forces for the Auto-disable Syringes Market

Porter’s Five Forces framework further strengthens the insights of the Auto-disable Syringes Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Auto-disable Syringes Market

External macro-environmental factors deeply influence the performance of the Auto-disable Syringes Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Auto-disable Syringes Market

The Auto-disable Syringes Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Auto-disable Syringes Market

The Auto-disable Syringes Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Auto-disable Syringes Market

The Auto-disable Syringes Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Auto-disable Syringes Market, highlighting leading vendors and their innovative profiles. These include AccuPoint by AdvaCare Pharma, Al Shifa Medical Products Co., Apple Syringe, Becton Dickinson & Company, Duopross Meditech Corp., Hindustan Syringes & Medical Devices Ltd, Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co., Injecto A/S, Iscon Surgicals Ltd., JMI SYRINGES & MEDICAL DEVICES LTD., Merck KGaA, PT Oneject Indonesia, Retractable Technologies, Inc., Sanavita Pharmaceuticals GmbH, Shandong Zhushi Pharmaceutical Group Co.,Ltd., Shanghai Kohope Medical Devices Co., Ltd., Shenzhen Medis Medical, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Auto-disable Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Indication
    • Infectious Diseases
    • Inflammatory/Auto-Immune Diseases
  • Application
    • Blood Collection
    • Drug Delivery
    • Vaccination
  • End-User
    • Ambulatory Surgical Centers
    • Diagnostic Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of needle stick injuries and cross infection
5.1.1.2. Significant preference of healthcare organizations towards the use of auto-disable syringes
5.1.1.3. Increasing demand for immunization coverage
5.1.2. Restraints
5.1.2.1. High cost of procurement and raw material
5.1.3. Opportunities
5.1.3.1. Increasing scope in mass application campaign
5.1.3.2. Ongoing advancements in auto-disable syringes
5.1.4. Challenges
5.1.4.1. Concern regarding unsafe injection practices and logistic challenges
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Auto-disable Syringes Market, by Indication
6.1. Introduction
6.2. Infectious Diseases
6.3. Inflammatory/Auto-Immune Diseases
7. Auto-disable Syringes Market, by Application
7.1. Introduction
7.2. Blood Collection
7.3. Drug Delivery
7.4. Vaccination
8. Auto-disable Syringes Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Diagnostic Laboratories
8.4. Hospitals
9. Americas Auto-disable Syringes Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Auto-disable Syringes Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Auto-disable Syringes Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. AUTO-DISABLE SYRINGES MARKET RESEARCH PROCESS
FIGURE 2. AUTO-DISABLE SYRINGES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AUTO-DISABLE SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. AUTO-DISABLE SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. AUTO-DISABLE SYRINGES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. AUTO-DISABLE SYRINGES MARKET DYNAMICS
TABLE 7. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFLAMMATORY/AUTO-IMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. AUTO-DISABLE SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. AUTO-DISABLE SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Auto-disable Syringes market, which are profiled in this report, include:
  • AccuPoint by AdvaCare Pharma
  • Al Shifa Medical Products Co.
  • Apple Syringe
  • Becton Dickinson & Company
  • Duopross Meditech Corp.
  • Hindustan Syringes & Medical Devices Ltd
  • Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co.
  • Injecto A/S
  • Iscon Surgicals Ltd.
  • JMI SYRINGES & MEDICAL DEVICES LTD.
  • Merck KGaA
  • PT Oneject Indonesia
  • Retractable Technologies, Inc.
  • Sanavita Pharmaceuticals GmbH
  • Shandong Zhushi Pharmaceutical Group Co.,Ltd.
  • Shanghai Kohope Medical Devices Co., Ltd.
  • Shenzhen Medis Medical
  • Terumo Corporation

Methodology

Table Information